No difference in percent Oligo-tau-laden RGC population was observed between MCI and AD (Fig. 4d), whereas a significant 1.7-fold further increase in Oligo-tau-laden RGC counts was detected in AD dementia compared to the MCI group (Fig. 4c; P < 0.05). The gene discussed is MAPT; the disease is Alzheimer disease.